IA-2 combined epitope assay: A new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes

Clinical Immunology

Volumn 115, Issue 3, 2005, Pages 260-267

  Tiberti, Claudio ^a   Verrienti, Antonella ^a   Fiore, Benedetta ^a   Yu, Liping ^b   Eisenbarth, George S ^b   Dotta, Francesco ^c   Di Mario, Umberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

Autoimmunity; Combined epitopes; Islet tyrosine phosphatase 2 (IA 2); Type 1 diabetes

Indexed keywords

AUTOANTIBODY; EPITOPE; ISLET TYROSINE PHOSPHATASE 2; PHOSPHATASE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOASSAY; IMMUNOREACTIVITY; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AUTOANTIBODIES; AUTOIMMUNITY; BASE SEQUENCE; BIOLOGICAL MARKERS; CHILD; DIABETES MELLITUS, TYPE 1; EPITOPES; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN-TYROSINE-PHOSPHATASE; SENSITIVITY AND SPECIFICITY;

EID: 19044379767     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.01.015     Document Type: Article

References (31)

1. M. Solimena, R. Dirkx, J.M. Hermel, S. Pleasic-Williams, J.A. Shapiro, L. Caron, and D.U. Rabin ICA512, an autoantigen of type 1 diabetes, is an intrinsic membrane protein of neurosecretory granules EMBO J. 15 1996 2102 2114
2. T. Ort, E. Maksimova, R. Dirkx, A.M. Kachinsky, S. Berghs, S.C. Froehner, and M. Solimena The receptor tyrosine phosphatase-like protein ICA 512 binds the PDZ domains of beta2-syntrophin and nNOS in pancreatic beta-cells Eur. J. Cell Biol. 79 2000 621 630
3. S. Berghs, D. Aggujaro, R. Dirkx, E. Maksimova, P. Stabach, J.M. Hermel, J.P. Zhang, W. Philbrick, V. Slepnev, T. Ort, and M. Solimena Beta IV spectrin, a new spectrin localized at axon initial segments and nodes of ranvier in the central and peripheral nervous system J. Cell. Biol. 151 2000 985 1002
4. K. Saeki, M. Zhu, A. Kubosaki, J. Xie, M.S. Lan, and A.L. Notkins Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion Diabetes 51 2002 1842 1850
5. D.U. Rabin, S.M. Pleasic, J.A. Shapiro, H. Yoo-Warren, J. Oles, J.M. Hicks, D.E. Goldstein, and P.M. Rae Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases J. Immunol. 152 1994 3183 3187
6. E. Bonifacio, V. Lampasona, S. Genovese, M. Ferrari, and E. Bosi Identification of protein tyrosine phosphatase-like (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies J. Immunol. 155 1995 5419 5426
7. T.M. Ellis, D.A. Schatz, E.W. Ottendorfer, M.S. Lan, C. Wasserfall, P.J. Salisbury, J.X. She, A.L. Notkins, N.K. Maclaren, and M.A. Atkinson The relationship between humoral and cellular immunity to IA-2 in IDDM Diabetes 47 1998 566 569
8. F. Dotta, S. Dionisi, V. Viglietta, C. Tiberti, M.C. Matteoli, M. Cervoni, C. Bizzarri, G. Marietti, M. Testi, G. Multari, L. Lucentini, and U. Di Mario T-cell mediated autoimmunity to the IA-2 islet tyrosine phosphatase in type 1 diabetes mellitus Eur. J. Endocrinol. 141 1999 272 278
9. M.S. Lan, C. Wasserfall, N.K. Maclaren, and A.L. Notkins IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus PNAS 93 1996 6367 6370
10. B.J. Bingley, E. Bonifacio, A.J.K. Williams, S. Genovese, G.F. Bottazzo, and E.A.M. Gale Prediction of IDDM in the general population: strategies based on combination of autoantibody markers Diabetes 46 1997 1701 1710
11. M. Hawa, R. Rowe, M.S. Lan, A.L. Notkins, P. Pozzilli, M.R. Christie, and R.D.G. Leslie Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes Diabetes 46 1997 1270 1275
12. C.F. Verge, R. Gianani, E. Kawasaki, L. Yu, M. Pietropaolo, R.A. Jackson, H.P. Chase, and G.S. Eisenbarth Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 autoantibodies Diabetes 45 1996 926 933
13. W.E. Winter, N. Harris, and D. Schatz Immunological markers in the diagnosis and prediction of autoimmune type 1a diabetes Clin. Diabetes 20 2002 183 191
14. J. Hawkes, N.C. Schloot, S.J.M. Willemen, J.W. Drijfhout, E.K. Majer, M.R. Christie, and B.O. Roep T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes Diabetes 49 2000 356 366
15. T. Lohmann, T. Halder, J. Engler, N.G. Morgenthaler, U.Y. Khoo-Morgenthaler, S. Schroder, J. Seissler, W.A. Scherbaum, and H. Kalbacher T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes Exp. Clin. Endocr. Diab. 107 1999 166 171
16. M. Peakman, E.J. Stevens, T. Lohmann, P. Narendran, J. Dromey, A. Alexander, A.J. Tomlinson, M. Trucco, J.C. Gorga, and R.M. Chicz Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4 J. Clin. Invest. 104 1999 1449 1457
17. V. Lampasona, M. Bearzatto, S. Genovese, E. Bosi, M. Ferrari, and E. Bonifacio Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen J. Immunol. 157 1995 2707 2711
18. B. Zhang, M.S. Lan, and A.L. Notkins Autoantibodies to IA-2 in IDDM Diabetes 46 1997 40 43
19. E. Kawasaki, L. Yu, R. Gianani, C.F. Verge, S. Babu, E. Bonifacio, and G.S. Eisenbarth Evaluation of islet cell antigen (ICA)512/IA-2 autoantibody radioassays using overlapping 512/IA-2 constructs J. Clin. Endocrinol. Metab. 82 1997 375 380
20. E. Kawasaki, L. Yu, M.J. Rewers, J.C. Hutton, and G.S. Eisenbarth Definition of multiple ICA/512 phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes Diabetes 47 1998 733 742
21. E. Bonifacio, V. Lampasona, and P.J. Bingley IA-2 (islet cell antigen is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens J. Immunol. 161 1998 2648 2654
22. H.N. Naserke, A.G. Ziegler, V. Lampasona, and E. Bonifacio Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes J. Immunol. 161 1998 6963 6969
23. M. Seissler, N. Schott, G. Morgenthaler, and W.A. Sherbaum Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2 Clin. Exp. Immunol. 122 2000 157 163
24. V. Kolm-Litty, S. Berlo, E. Bonifacio, M. Bearzatto, A.M. Engel, M. Christie, A.G. Ziegler, T. Wilde, and J. Endl Human monoclonal antibodies isolated from type 1 diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen J. Immunol. 165 2000 4676 4684
25. C.F. Verge, D. Stenger, E. Bonifacio, P.G. Colman, C. Pilcher, P.J. Bingley, G.S. Eisenbarth, and Participating Laboratories Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes Diabetes 47 1998 1857 1866
26. P.J. Bingley, E. Bonifacio, P.W. Mueller, and Participating Laboratories Diabetes antibody standardization program: first assay proficiency evaluation Diabetes 52 2003 1128 1136
27. E. Kawasaki, Y. Sera, N. Fujita, M. Yamauchi, M. Ozaki, T. Abe, K. Yamakawa, S. Uotani, H. Takino, H. Yamasaki, Y. Yamaguchi, Y. Uchigata, N. Matsuura, and K. Eguchi Association between IA-2 autoantibody epitope specificities and age of onset in Japanese patients with autoimmune diabetes J. Autoimmun. 17 2001 323 331
28. Y.S. Park, E. Kawasaki, K. Kelemen, L. Yu, M.R. Schiller, M. Rewers, M. Mizuta, G.S. Eisenbarth, and J.C. Hutton Humoral autoreactivity to an alternatively spliced variant of ICA512/IA-2 in type 1 diabetes Diabetologia 43 2000 1293 1301
29. C.E. Grubin, T. Daniels, B. Toivola, M. Landin-Olsson, W.A. Hagopian, L. Li, A.E. Karlsen, E. Boel, B. Michelsen, and A. Lernmark A novel radioligand binding assay to determine diagnostic accuracy of isoform specific glutamic acid decarboxylase in a childhood population Diabetologia 37 1994 344 350
30. M. Bearzatto, V. Lampasona, C. Belloni, and E. Bonifacio Fine mapping of diabetes-associated IA-2 specific autoantibodies J. Autoimmun. 21 2003 377 382
31. R.D. Leslie, M.A. Atkinson, and A.L. Notkins Autoantigens IA-2 and GAD in Type 1 (insulin-dependent) diabetes Diabetologia 42 1999 3 14